Phinomics develops genome-based technologies to detect disorders and identify disease-specific genetic markers using circular DNA, known as Circulomes. By leveraging this technology, Phinomics aims to improve human health by enabling early detection of diseases and providing personalized genomic information. The company was founded in 2020 and is based in San Carlos, California.